M&A Deal Summary |
|
|---|---|
| Date | 2023-07-12 |
| Target | IPOC |
| Sector | Life Science |
| Buyer(s) | Fortis Life Sciences |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2020 |
| Sector | Life Science |
Fortis Life Sciences is a strategic platform company providing capital, expertise, and operational resources to enable the growth and success of founder-led life sciences tools companies. Fortis Life Sciences was established in 2020 and is headquartered in Boston, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| State: Ontario M&A | 1 of 1 |
| Country: Canada M&A | 1 of 1 |
| Year: 2023 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-03-02 |
Abcore
Ramona, California, United States Abcore provides antibody and nanobody products and services. Abcore has built an entire platform for nanobody and single domain (VHH) antibody discovery, based on proprietary phage display libraries. The Company offers end-to-end discovery and development capabilities and custom antibody production. Abcore was founded in 2011 and is based in Ramona, California. |
Buy | - |
